Our research group recently showed that, in patients with acromegaly living in highly polluted areas, germline AHR rs2066853 variant, associate with a more severe clinical and biochemical phenotype, with larger and more invasive somatotropinomas and resistance to somatostatin analogs treatment (13–15). This evidence concerns the gene AHR and acromegaly.